US Healthcare Industry Outlook Report 2025: Pharma and Medical Device Competitive Landscape, Market Assessment, Access Insights, and PESTLE Analysis - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "US Healthcare Outlook Report, 2025" report has been added to ResearchAndMarkets.com's offering.

The report provides comprehensive insights about healthcare scenario, regulatory policies and reimbursement landscape in US. The report also identifies key trends in the healthcare market and provide insights into the demographic and healthcare infrastructure of the country. Along with this the report also provides a brief look into the trends and segmentation of the pharmaceutical and medical devices market of US.

US is headquarter to various major pharmaceutical and medical device companies of the world. Due to this, US pharmaceutical market is the world's most important national market.

Major Pharmaceutical Companies in the US Healthcare Market

The US is the worldwide leader in per capita prescription drug spending. Many global pharmaceutical companies also have a presence in the US Further, US is hub for various ongoing clinical trials. In the US, the majority of the pharmaceutical wholesaler business is concentrated in a few companies that hold the majority of the market share. There is also a large market in the US for over-the-counter (OTC) medicines. Drugs for conditions like allergies and heartburn that required prescriptions in the past are now available for OTC sale. Use of generic drugs has also increased in recent years.

US government's plan to implement of cost control policies along with tightening of rules by government like delay in approval of complex generics and price erosion in US generics pharmaceuticals market are expected to impact the growth prospect of the US pharmaceuticals industry. Pharmaceuticals companies are forced to reduce their research and development (R&D) spending due to slowdown of growth in last few years which is also expected to hamper growth of the US pharma market as new drugs revenue form large part of pharma firm's revenue due to exclusivity of the drug.

Major Medical Device Companies in the US Healthcare Market

The US medical device industry is one of the largest in the world, with billions of dollars in annual revenue. It contributes significantly to the US economy and provides employment to a substantial workforce, including engineers, scientists, regulatory experts, and manufacturing professionals.

Medical devices in the US are subject to rigorous regulation by the US Food and Drug Administration (FDA). The FDA classifies devices into different categories (Class I, II, and III) based on their risk profile. The level of regulatory scrutiny increases with the device's risk level, with Class III devices requiring the highest level of oversight.

Medical device manufacturers must obtain FDA clearance or approval before marketing their products in the US The approval process involves demonstrating safety and effectiveness through clinical trials for certain devices, while others can enter the market through the 510(k) clearance pathway if they are substantially equivalent to a legally marketed device.

US Healthcare Assessment

This chapter contains the statistical information containing, number of hospitals, number of beds, number of pharmacies, life expectancy of male and female, Immunization coverage for Hepatitis B and Measles, environmental health (PM 2.5 and CO2 Emissions), number of physicians, nurses, dentists and pharmacists, healthcare expenditure, healthcare expenditure as share of GDP, out of pocket expenditure, pharmaceutical import and export, Gross Domestic Product, Inflation, Unemployment, trade associations and trade fairs in US.

US: Market Access

Market access section of the US Healthcare Outlook report contains information on how to penetrate the pharmaceutical and medical device markets in terms of setting up manufacturing unit, import export licensing, regulations pertaining to patents, trademarks, clinical trials, advertising, pharmacy regulation, labelling and packaging. It also covers detail about healthcare insurance and reimbursement policy.

US Department of Health and Human Services (HHS) is the primary federal agency responsible for overseeing healthcare policy and regulation. It includes several sub-agencies that play significant roles such as Centers for Medicare & Medicaid Services (CMS) which administers the nation's major healthcare programs, including Medicare and Medicaid; Agency for Healthcare Research and Quality (AHRQ) that conducts research to improve the quality and safety of healthcare, amongst others.

US: PESTLE Analysis

The US Healthcare Outlook report covers a thorough analysis of the country through PESTLE analysis tool and give political, economic, social, technological, legal and environmental aspects of healthcare industry.

Key Questions

• What are business strategies and trends shaping and driving the US healthcare market?
• What are reimbursement and regulatory policies, pharmaceutical and medical device market segments and companies likely to impact the US healthcare market in the future?
• How to organize sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment and strategic partnership?
• How to identify, understand and capitalize on the opportunities and challenges in the US healthcare market?

Key Companies in the US Healthcare Market

• Pfizer
• Johnson & Johnson
• Roche
• AbbVie
• Amgen
• Novartis
• Merck & Co.
• Gilead Sciences
• Sanofi
• Bristol-Myers Squib
• B. Braun

Key Topics Covered:

1. Key Insights

2. United States Healthcare Market at a Glance

3. Executive Summary

4. United States Statistics on Health

4.1. Life Expectancy

4.2. Major prevalent Indications/Diseases

4.3. Mortality and Mortality Rate by major causes

5. United States Healthcare Economics

5.1. National Health Care Expenditures

5.2. National Health Care Expenditures and Share by Source of Revenues

5.3. Healthcare Expenditure as share of GDP

5.4. Out of Pocket Expenditure as share of current health expenditure

5.5. Gross Domestic Product

5.6. Inflation

5.7. Unemployment

5.8. Trade Association

5.9. Trade Fairs

6. Pharmaceutical Manufacturers

6.1. Number of Pharmaceutical Manufacturers

7. Pharmaceutical Market

7.1. Key Players

7.2. Pharmaceutical Market -Manufacturers Sales

7.3. Sales of Pharmaceutical Manufacturers by Capital Scale

7.4. Comparison of Pharmaceutical Sales between Domestic and Foreign Companies

7.5. Financial Results of the Leading (Top 10) Pharmaceutical Manufacturers

8. Exports and Imports

8.1. Regulation of Import and Export

8.2. International Trade of Pharmaceutical Products

8.3. International Trade of Pharmaceutical Products by Partner Countries

8.4. Technology Exports and Imports in the Pharmaceutical Industry

9. Healthcare in United States: Overview

9.1. Key Reforms in United States Healthcare Market

9.2. Pharmaceutical Market Size & Distribution Assessment

9.3. Healthcare Facility Administrative Structure

9.4. Governmental Healthcare Policy

9.5. Healthcare Insurance System

10. United States Healthcare Industry: Overview

10.1. Pharmaceutical

10.1.1. Supply Channels

10.1.2. Major Players

10.1.3. Prescription VS OTC Drugs

10.2. Medical Device

10.2.1. Supply Chain

10.2.2. Major Distributors

11. Healthcare Infrastructure

11.1. Hospitals and Clinics

11.2. Healthcare Personnel

12. Regulatory Landscape

12.1. Healthcare Policies

12.2. Pharmaceutical Regulations

12.3. Health Insurance System

13. United States Healthcare Regulations

13.1. Regulatory Approval Process

13.2. Major Regulatory bodies and Stakeholders

13.3. Market/Data Exclusivity

14. Healthcare Provisions in United States

14.1. Healthcare Facilities (Beds, Hospitals and Pharmacy)

14.2. Healthcare Workforce (Physicians, Dentists and Nurses)

15. Healthcare Market Access in United States

15.1. Reimbursement Process

15.2. Health Insurance

15.3. Pricing Policies

15.4. Regulatory Landscape

15.4.1. Market Authorization for Pharmaceutical Products

15.4.2. Market Authorization for Medical Devices

15.4.3. Licensing Process for Pharmaceutical and Medical Device Manufacturing

15.4.4. Licensing Process for Pharmaceutical Exports and Imports

15.4.5. Intellectual Property Rights

15.4.5.1. Patent

15.4.5.2. Trademark

15.4.6. Clinical Trial Regulations

15.4.6.1. Pharmaceutical Clinical Trials Landscape

15.4.6.2. Medical Device Clinical Trials Landscape

15.4.7. Pharmaceutical Advertising Regulations

15.4.8. Medical Device Advertising Regulations

15.4.9. Pharmacy Regulations

15.4.10. Labeling and Packaging Regulations

16. Case Studies

16.1. Successful Healthcare Initiatives

16.2. Innovative Partnerships

17. United States Healthcare Market Assessment

17.1. By Drug Type

17.1.1. Prescription

17.1.1.1. Branded

17.1.1.2. Generic

17.1.2. Over-the-counter (OTC)

17.2. By Therapy Area

17.2.1. Oncology

17.2.2. Cardiology

17.2.3. Neurology

17.2.4. Musculoskeletal

17.2.5. Infectious

17.2.6. Others

17.3. Key Pharmaceutical and Medical Device Players in United States

18. Healthcare Market Dynamics

18.1. Market Drivers

18.2. Market Opportunities

18.3. Market Restrains and Challenges

19. United States PESTLE Analysis

20. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/6ut0ee

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.